Editorji is a popular short video news and information platform based in India. It was founded in 2018 by Vikram Chandra, one of India’s leading journalists, and has risen to prominence in the digital news space in a relatively short span of time. The platform is primarily designed for mobile devices, with applications available for Android and iOS.

ABOUT US:

about us editorji

Latest Video News: Editorji provides the latest news video headlines, latest videos clip from India and the World. Get all breaking news videos on Entertainment, Business, Coronavirus, Elections, Politics and more.

Latest Video News, Breaking News, Bollywood, Political, Sports, Business News | Editorji

+91 11 4035 6666 / info@editorji.com
3rd floor, Plot B, Khasara no 360, Sultanpur, New Delhi, Delhi 110030
<a title="mail to us" href="mailto:info@editorji.com">Send Feedback</a>
<a title="Contact Us" href="mailto:info@editorji.com">Contact Us</a>

REACH US

Contact for any questions, suggestions, comments, feedback or advertisement on Editorji.com, we are always looking forward to hearing from you.

Contact Us for Feedback, Suggestions and Advertising 

Editorji content is better experienced in our app.

Amid reports that the govt may be inclined to grant indemnity from liability to foreign drug companies such as Pfizer and Moderna, Serum Institute of India has also demanded the same, reports said quoting sources. "Not just Serum Institute of India, all the vaccine companies should get indemnity protection against liabilities if foreign companies are granted it," reports said quoting Serum sources. Serum Institute is producing AstraZeneca's Covishield vaccine.Indemnity from liability is a key condition put forth by vaccine-makers Pfizer and Moderna for supplying their Covid shots to India.The govt has so far not given such a relaxation to any vaccine maker.

'Same rules': Serum Institute too seeks indemnity protection, say reports

Amid reports that the govt may be inclined to grant indemnity from liability to foreign drug companies such as Pfizer and Moderna, Serum Institute of India has also demanded the same: reports

'Same rules': Serum too seeks indemnity protection, say reports

Amid reports that the govt may be inclined to grant indemnity from liability to foreign drug companies such as Pfizer and Moderna, Serum Institute of India has also demanded the same, reports said quoting sources. "Not just Serum Institute of India, all the vaccine companies should get indemnity protection against liabilities if foreign companies are granted it," reports said quoting Serum sources. Serum Institute is producing AstraZeneca's Covishield vaccine. Indemnity from liability is a key condition put forth by vaccine-makers Pfizer and Moderna for supplying their Covid shots to India. The govt has so far not given such a relaxation to any vaccine maker.

The indemnity roadblock set to be removed paving the way for Pfizer, Moderna&nbsp;vaccines to be imported into India. Reports indicate that the govt is gearing to grant indemnity&nbsp;from legal liability to the pharma&nbsp;giants.&nbsp;Pfizer who has stated that they have 5 crore&nbsp;doses ready to be imported into India had demanded an indemnity clause to finalise the deal. Such a clause absolves the pharma&nbsp;major from any legal liability in case of any adverse effects. Cipla also had approached the govt seeking the same for Moderna&nbsp;as the company is looking to import 50 million doses of the vaccine as they become available.&nbsp;

Indemnity roadblock set to be removed, paving the way for Pfizer

Indemnity roadblock set to be removed, paving the way for Pfizer vaccine

The indemnity roadblock set to be removed paving the way for Pfizer, Moderna&nbsp;vaccines to be imported into India. Reports indicate that the govt is gearing to grant indemnity&nbsp;from legal liability to the pharma&nbsp;giants.&nbsp; Pfizer who has stated that they have 5 crore&nbsp;doses ready to be imported into India had demanded an indemnity clause to finalise the deal. Such a clause absolves the pharma&nbsp;major from any legal liability in case of any adverse effects. Cipla also had approached the govt seeking the same for Moderna&nbsp;as the company is looking to import 50 million doses of the vaccine as they become available.&nbsp;

indemnity

Categories